Targeting the NLRP3 Inflammasome for the Treatment of Alzheimer’s

Time: 9:00 am
day: Day Two

Details:

  • Learning how persistent NLRP3 inflammasome signaling propagates neuroinflammation in aged brains, and promotes AD pathogenesis and progression
  • Hearing how recent data confirms the essential role of NEK7 in the assembly of NLRP3 complex
  • Discovering how Halia is the first to target NEK7 to block the formation of NLRP3 inflammasome complex

Speakers: